| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.71 | $3.80 | +2.5% |
| Q2'26 | $3.75 | $2.93 | -21.9% |
| Q1'26 | $3.78 | $3.94 | +4.3% |
| Q4'25 | $3.72 | $3.94 | +5.9% |
| Q3'25 | $2.97 | $3.03 | +2.0% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $18.9B | $18.7B | -1.1% |
| Q2'26 | $18.7B | $18.0B | -3.7% |
| Q1'26 | $18.7B | $18.7B | +0.2% |
| Q4'25 | - | $18.7B | - |
| Q3'25 | - | $17.6B | - |
Market Data
ACN is currently trading at $144.00, giving Accenture plc a market cap of 85.26B and a P/E ratio of 10.9. Today's range spans $139.01–$144.50, with shares opening at $143.76 and moving down $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 59/100 (HOLD) with a news sentiment reading of 79/100.
Over the past year ACN has traded between $118.15 and $291.09 - the current price is +21.9% off the 52-week low and -50.5% from the high. 34 analysts cover the stock with a Buy consensus and a mean 12-month target of $179.13 (range $130.00–$275.00), implying upside of +24.4%.
ACN sits at $144.00 (near 52-week lows) with a HOLD technical read (59/100) and bullish sentiment (79/100). The 85.26B market cap in Technology (P/E: 10.9) makes this a name that institutional coverage maintains even through neutral phases - which means any catalyst shift will be quickly priced in. Annual range: $118.15–$291.09.
The 52-week range of $118.15–$291.09 for ACN provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $144.00 (near 52-week lows), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 59/100 and bullish news backdrop (79/100) don't break the tie yet, but they narrow the probability distribution toward the upside.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).